Loureirin B inhibits Cervical Cancer Development by Blocking PI3K/AKT Signaling Pathway: Network Pharmacology Analysis and Experimental Validation.
- Published in:
- Applied Biochemistry & Biotechnology, 2024, v. 196, n. 12, p. 8587, doi. 10.1007/s12010-024-04975-7
- By:
- Publication type:
- Article